These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 15971886

  • 1. [Effects of intravascular contrast media on urinary excretion of liver fatty acid-binding protein].
    Ohta S, Ishimitsu T, Minami J, Ono H, Matsuoka H.
    Nihon Jinzo Gakkai Shi; 2005; 47(4):437-44. PubMed ID: 15971886
    [Abstract] [Full Text] [Related]

  • 2. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy.
    Nakamura T, Sugaya T, Node K, Ueda Y, Koide H.
    Am J Kidney Dis; 2006 Mar; 47(3):439-44. PubMed ID: 16490622
    [Abstract] [Full Text] [Related]

  • 3. Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy.
    Hofstra JM, Deegens JK, Steenbergen EJ, Wetzels JF.
    Nephrol Dial Transplant; 2008 Oct; 23(10):3160-5. PubMed ID: 18403431
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [L-type fatty acid binding protein (L-FABP) and kidney disease].
    Kamijo-Ikemori A, Sugaya T, Kimura K.
    Rinsho Byori; 2014 Feb; 62(2):163-70. PubMed ID: 24800492
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice.
    Kamijo-Ikemori A, Sugaya T, Matsui K, Yokoyama T, Kimura K.
    Nephrology (Carlton); 2011 Aug; 16(6):539-44. PubMed ID: 21504508
    [Abstract] [Full Text] [Related]

  • 13. Urinary lipocalin-type prostaglandin D synthase: a potential marker for early gentamicin-induced renal damage?
    Nakayama H, Echizen H, Gomi T, Shibuya Y, Nakamura Y, Nakano K, Arashi H, Itai T, Ohnishi S, Tanaka M, Orii T.
    Ther Drug Monit; 2009 Feb; 31(1):126-30. PubMed ID: 19125150
    [Abstract] [Full Text] [Related]

  • 14. [Contrast nephropathy with a non-ionic iodide medium in patients with normal and mildly impaired renal function].
    Usutani S.
    Nihon Jinzo Gakkai Shi; 2000 May; 42(4):338-45. PubMed ID: 10897593
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of pitavastatin on urinary liver-type fatty-acid-binding protein in patients with nondiabetic mild chronic kidney disease.
    Nakamura T, Sugaya T, Kawagoe Y, Suzuki T, Inoue T, Node K.
    Am J Nephrol; 2006 May; 26(1):82-6. PubMed ID: 16534182
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Urinary fatty acids and liver-type fatty acid binding protein in diabetic nephropathy.
    Sasaki H, Kamijo-Ikemori A, Sugaya T, Yamashita K, Yokoyama T, Koike J, Sato T, Yasuda T, Kimura K.
    Nephron Clin Pract; 2009 May; 112(3):c148-56. PubMed ID: 19390215
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function.
    Fujisaki K, Kubo M, Masuda K, Tokumoto M, Hirakawa M, Ikeda H, Matsui R, Matsuo D, Fukuda K, Kanai H, Hirakata H, Iida M.
    Clin Exp Nephrol; 2003 Dec; 7(4):279-83. PubMed ID: 14712357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.